Followers | 37 |
Posts | 4190 |
Boards Moderated | 0 |
Alias Born | 10/18/2016 |
Monday, October 02, 2017 10:22:55 AM
Health care software-as-a-service company ORHub, Inc. (OTC: ORHB) this morning announced that it has successfully completed over 2,000 surgeries at a leading surgical institution in Southern California, putting it ahead of schedule as its national rollout strategy gets underway. “As a result of heightened awareness of the increasingly urgent need to streamline healthcare, we have met with dozens of inquiring surgical management teams from major institutions across the country, which collectively represent hundreds of hospitals,” Colt Melby, CEO of ORHub, stated in the news release. “We believe that ORHub’s unrivaled technology will have a significant impact on hospital efficiency, profitability and overall patient care. There are over 100 million surgical procedures performed in the U.S. every year, and hospitals continue to seek ways to be more efficient and cost effective.” Following the recent launch of its new orthopedic service line, ORHub is currently focused on the delivery of advanced real-time data analytics in the relatively untapped surgical sector. In line with this focus, ORHub’s flagship institution is a major hospital that exclusively utilizes its ORHub Surgical Management Platform for all surgeries performed at its facility.
To view the full press release, visit http://nnw.fm/0pNQT
About ORHub, Inc.
ORHub is a medical software company focused on delivering case-based data analytics at the speed of surgery. The Company’s suite of products serves the needs of the health care industry, hospital, patient, government and the medical device vendor. ORHub provides a cloud-based software solution that captures information before, during and after surgery, filling a void in the current surgical information infrastructure and providing the first process to capture and measure the surgical process — evolving Big Data into Intelligent Digital Data. For more information, visit www.ORHub.com
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM